Skip to main content

Logo
  • Live News iconLive News
  • Smart Screener iconSmart Screener
  • Trade Opportunities iconTrade Opportunities
  • Alpha Watch iconAlpha Watch
  • Catalyst iconCatalyst
Skip to main content
Stock Ask Logo
Hi, Guest User

Log in or create an account to get full access

Open an Account (opens in a new window)

TOOLS

Live News
Smart Screener
Trade Opportunities
Alpha Watch
Catalyst

StockkASK powered by Indira Securities

Accretion Nutraveda Ltd (ANL) Share Price & Fundamentals

Company Overview

Founded Year

2021

Listed Year

2025

Headquarter

Ahmedabad, India

MD/CEO

-

Website

-

Company Facts

What we do

Accretion Nutraveda Ltd is a healthcare-focused CDMO specializing in ayurvedic and nutraceutical products including tablets, capsules, oral liquids, powders, oils, and external preparations.

Founded in

2,021

Market share

-

Problem solved

Provides specialized contract development and manufacturing services to clients in ayurvedic and nutraceutical segments, ensuring high-quality diverse dosage forms.

Top clients or who we serve

Clients across various industries seeking ayurvedic and nutraceutical product manufacturing; operates in B2B space.

Key management

-

Our journey and innovations

Incorporated in 2021, converted to public limited company in 2025; blends classical ayurvedic principles with modern nutraceutical science.

Where we operate

India primarily; plans to expand with IPO funding.

Top products or what we offer

Tablets (film-coated, chewable), capsules (hard gelatin, HPMC), oral liquids, traditional powders, medicated oils, external preparations.

Top brands

-

Raw materials needed

Herbal extracts, ayurvedic raw materials, excipients for tablets/capsules.

Raw materials supplier

-

Recurring vs cyclical contribution

Revenue likely cyclical, project-based from contract manufacturing.

Our industry position

-

Financial highlights

FY 2024–25 revenue Rs 16 crore, net profit Rs 2.61 crore.

Geographical revenue split

-

Order book

-

Whats driving growth

Rising demand for ayurvedic nutraceuticals and outsourcing production by healthcare companies.

Our future plans

IPO planned to raise capital; aim to expand capacity and product range.

Our green promise

-

Our people and values

-

Key challenges ahead

Scaling production, regulatory compliance, competition in nutraceutical manufacturing.

Interesting facts

-

Risks and strategy

-

Market Footprint

Top Clients

Top Clients

Clients across various industries seeking ayurvedic and nutraceutical product manufacturing; operates in B2B space.

Top Products

Top Products

Tablets (film-coated, chewable), capsules (hard gelatin, HPMC), oral liquids, traditional powders, medicated oils, external preparations.

Price Movement & Share Holding

Today's High/Low

290290

52 Week High/Low

150.1313
Past Returns

1 week

-1.69%

1 month

7.49%

3 month

2.11%

1 year

51.67%

3 year

51.67%

5 year

51.67%

Share Holding

Promoters

73.48%

FII

1.08%

DII

5.11%

Retail

17.09%

Others

3.25%

Company Overview

Founded Year

2021

Listed Year

2025

Headquarter

Ahmedabad, India

MD/CEO

-

Website

-

Price Movement & Share Holding

Today's High/Low

290290

52 Week High/Low

150.1313

Past Returns

1 week

-1.69%

1 month

7.49%

3 month

2.11%

1 year

51.67%

3 year

51.67%

5 year

51.67%

Share Holding

Promoters

73.48%

FII

1.08%

DII

5.11%

Retail

17.09%

Others

3.25%

Company Facts

What we do

Accretion Nutraveda Ltd is a healthcare-focused CDMO specializing in ayurvedic and nutraceutical products including tablets, capsules, oral liquids, powders, oils, and external preparations.

Founded in

2021

Problem solved

Provides specialized contract development and manufacturing services to clients in ayurvedic and nutraceutical segments, ensuring high-quality diverse dosage forms.

Top clients or who we serve

Clients across various industries seeking ayurvedic and nutraceutical product manufacturing; operates in B2B space.

Our journey and innovations

Incorporated in 2021, converted to public limited company in 2025; blends classical ayurvedic principles with modern nutraceutical science.

Where we operate

India primarily; plans to expand with IPO funding.

Top products or what we offer

Tablets (film-coated, chewable), capsules (hard gelatin, HPMC), oral liquids, traditional powders, medicated oils, external preparations.

Raw materials needed

Herbal extracts, ayurvedic raw materials, excipients for tablets/capsules.

Recurring vs cyclical contribution

Revenue likely cyclical, project-based from contract manufacturing.

Financial highlights

FY 2024–25 revenue Rs 16 crore, net profit Rs 2.61 crore.

Whats driving growth

Rising demand for ayurvedic nutraceuticals and outsourcing production by healthcare companies.

Our future plans

IPO planned to raise capital; aim to expand capacity and product range.

Key challenges ahead

Scaling production, regulatory compliance, competition in nutraceutical manufacturing.

Market Footprint

Top Clients

Top Clients

Clients across various industries seeking ayurvedic and nutraceutical product manufacturing; operates in B2B space.

Top Products

Top Products

Tablets (film-coated, chewable), capsules (hard gelatin, HPMC), oral liquids, traditional powders, medicated oils, external preparations.

StockkASK provides smart, AI-powered insights to support analysis. AI can make mistakes; verify independently before investing.Terms & Conditions